NO822062L - Substituerte imidazo(1,5-alfa)pyridiner, fremgangsmaate til deres fremstilling, farmasoeytiske preparater inneholdende disse forbindelser samt deres terapeutiske anvendelse - Google Patents

Substituerte imidazo(1,5-alfa)pyridiner, fremgangsmaate til deres fremstilling, farmasoeytiske preparater inneholdende disse forbindelser samt deres terapeutiske anvendelse

Info

Publication number: NO822062L
Authority: NO; Norway
Prior art keywords: pyridines; alfa; procedures; compounds; preparation
Prior art date: 1981-06-22

Application number

NO822062A

Other languages

English (en)

Other versions

NO159276B (no

NO159276C (no

Inventor

Neville Ford

Original Assignee

Ciba Geigy Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1981-06-22

Filing date

1982-06-21

Publication date

1982-12-23

1982-06-21 Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag

1982-12-23 Publication of NO822062L publication Critical patent/NO822062L/no

1988-09-05 Publication of NO159276B publication Critical patent/NO159276B/no

1988-12-14 Publication of NO159276C publication Critical patent/NO159276C/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/32—Compounds having groups or groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/57—Nitriles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Hematology (AREA)
Diabetes (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)

NO822062A 1981-06-22 1982-06-21 Analogifremgangsmaate til fremstilling av terapeutisk virksomme imidazo(1,5-a)pyridiner. NO159276C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US27609481A	1981-06-22	1981-06-22

Publications (3)

Publication Number	Publication Date
NO822062L true NO822062L (no)	1982-12-23
NO159276B NO159276B (no)	1988-09-05
NO159276C NO159276C (no)	1988-12-14

Family

ID=23055137

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO822062A NO159276C (no)	1981-06-22	1982-06-21	Analogifremgangsmaate til fremstilling av terapeutisk virksomme imidazo(1,5-a)pyridiner.

Country Status (20)

Country	Link
EP (1)	EP0068386B1 (no)
JP (1)	JPS58979A (no)
KR (1)	KR890002640B1 (no)
AR (1)	AR242032A1 (no)
AT (1)	ATE17004T1 (no)
AU (1)	AU559666B2 (no)
CA (1)	CA1250844A (no)
DE (1)	DE3268010D1 (no)
DK (1)	DK158227C (no)
ES (5)	ES8401069A1 (no)
FI (1)	FI75569C (no)
GB (1)	GB2101595B (no)
GR (1)	GR76844B (no)
HU (1)	HU190701B (no)
IE (1)	IE53396B1 (no)
IL (1)	IL66101A (no)
NO (1)	NO159276C (no)
NZ (1)	NZ201023A (no)
PT (1)	PT75084B (no)
ZA (1)	ZA824355B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4444775A (en) *	1981-06-22	1984-04-24	Ciba-Geigy Corporation	Substituted imidazo[1,5-A]pyridines
EP0098690B1 (en) *	1982-06-14	1987-09-09	Takeda Chemical Industries, Ltd.	Vinyl carboxylic acid derivatives, their production and use
US4588732A (en) *	1982-12-21	1986-05-13	Ciba-Geigy Corporation	Certain imidazo(1,5-a)pyridine derivatives and their use as thromboxane synthetase inhibitors
US4617307A (en) *	1984-06-20	1986-10-14	Ciba-Geigy Corporation	Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
US4470986A (en) *	1982-12-21	1984-09-11	Ciba-Geigy Corporation	Certain imidazo (1,5-A) pyridine aliphatic carboxylic acid derivatives and their use as selective thromboxane inhibitors
ES2036128B1 (es) *	1991-07-10	1993-12-16	Menarini Lab	Procedimiento para la preparacion de 4-(imidazo)1,5-a)piridin-8l)-1,4-dihidropiridinas.
US5468757A (en) *	1994-01-31	1995-11-21	Eli Lilly And Company	6-azaindole thromboxane synthase inhibitors
EP1565463B1 (en) *	2002-11-18	2008-06-11	Novartis AG	Imidazo[1,5a] pyridine derivatives and methods for treating aldosterone mediated diseases
US7803810B2 (en)	2007-03-09	2010-09-28	Probiodrug Ag	Inhibitors

1982
- 1982-06-18 FI FI822199A patent/FI75569C/fi not_active IP Right Cessation
- 1982-06-18 CA CA000405476A patent/CA1250844A/en not_active Expired
- 1982-06-18 GB GB08217704A patent/GB2101595B/en not_active Expired
- 1982-06-21 ZA ZA824355A patent/ZA824355B/xx unknown
- 1982-06-21 IL IL66101A patent/IL66101A/xx not_active IP Right Cessation
- 1982-06-21 PT PT75084A patent/PT75084B/pt not_active IP Right Cessation
- 1982-06-21 DE DE8282105426T patent/DE3268010D1/de not_active Expired
- 1982-06-21 AT AT82105426T patent/ATE17004T1/de not_active IP Right Cessation
- 1982-06-21 EP EP82105426A patent/EP0068386B1/de not_active Expired
- 1982-06-21 NO NO822062A patent/NO159276C/no unknown
- 1982-06-21 GR GR68489A patent/GR76844B/el unknown
- 1982-06-21 ES ES513307A patent/ES8401069A1/es not_active Expired
- 1982-06-21 AU AU85067/82A patent/AU559666B2/en not_active Ceased
- 1982-06-21 NZ NZ201023A patent/NZ201023A/en unknown
- 1982-06-21 IE IE1458/82A patent/IE53396B1/en not_active IP Right Cessation
- 1982-06-21 DK DK277682A patent/DK158227C/da not_active IP Right Cessation
- 1982-06-21 KR KR8202756A patent/KR890002640B1/ko not_active Expired
- 1982-06-21 HU HU822011A patent/HU190701B/hu not_active IP Right Cessation
- 1982-06-22 JP JP57106292A patent/JPS58979A/ja active Granted
1983
- 1983-09-16 ES ES525687A patent/ES8502995A1/es not_active Expired
- 1983-09-16 ES ES525686A patent/ES525686A0/es active Granted
- 1983-09-16 ES ES525688A patent/ES8502996A1/es not_active Expired
- 1983-09-16 ES ES525689A patent/ES8502997A1/es not_active Expired
1984
- 1984-01-19 AR AR84295476A patent/AR242032A1/es active

Also Published As

Publication number	Publication date
NO159276B (no)	1988-09-05
HU190701B (en)	1986-10-28
CA1250844A (en)	1989-03-07
IE53396B1 (en)	1988-11-09
IE821458L (en)	1982-12-22
NZ201023A (en)	1985-08-30
FI75569C (fi)	1988-07-11
FI822199A0 (fi)	1982-06-18
FI822199L (fi)	1982-12-23
JPH0347277B2 (no)	1991-07-18
EP0068386A1 (de)	1983-01-05
ES525689A0 (es)	1985-02-01
PT75084B (en)	1985-07-26
PT75084A (en)	1982-07-01
ES8502997A1 (es)	1985-02-01
NO159276C (no)	1988-12-14
ES525687A0 (es)	1985-02-01
IL66101A (en)	1985-06-30
FI75569B (fi)	1988-03-31
KR840000545A (ko)	1984-02-25
ES525688A0 (es)	1985-02-01
JPS58979A (ja)	1983-01-06
EP0068386B1 (de)	1985-12-18
KR890002640B1 (ko)	1989-07-21
ES8502995A1 (es)	1985-02-01
ES8502996A1 (es)	1985-02-01
ES513307A0 (es)	1983-12-01
DK158227C (da)	1990-09-17
DK158227B (da)	1990-04-16
AR242032A1 (es)	1993-02-26
ZA824355B (en)	1983-04-27
ATE17004T1 (de)	1986-01-15
AU559666B2 (en)	1987-03-19
GB2101595B (en)	1985-05-30
GR76844B (no)	1984-09-04
GB2101595A (en)	1983-01-19
ES8502994A1 (es)	1985-02-01
DE3268010D1 (en)	1986-01-30
DK277682A (da)	1982-12-23
AU8506782A (en)	1983-01-06
ES8401069A1 (es)	1983-12-01
ES525686A0 (es)	1985-02-01

Publication	Publication Date	Title
DK164868C (da)	1993-01-11	Imidazooe4,5-baaquinolin-2-on-derivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
DK393482A (da)	1983-03-04	Urinstofderivater, fremgangsmaade til fremstilling heraf og medikamenter indeholdende disse forbindelser samt deres anvendelse
DK214090A (da)	1990-09-06	5-aminosulfonylalkyl-indolderivater, fremgangsmaade og mellemprodukt til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
DK356885D0 (da)	1985-08-06	3-aminomethyl-imidazo(1,2-a)pyridinderivater samt fremgangsmaade til fremstilling af og laegemiddel indeholdende saadanne forbindelser
NO820200L (no)	1982-07-26	Fremgangsmaate til fremstilling av fosforylforbindelser, i foerste rekke heksapyranoseforbindelser samt farmasoeytiske preparater inneholdende disse
NO854194L (no)	1986-04-23	Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende antracyklinglykosider.
DK160492C (da)	1991-08-26	Pyrimidinderivater, fremgangsmaader til fremstilling heraf samt farmaceutiske praeparater indeholdende disse derivater
DK542584D0 (da)	1984-11-15	1,3-dihydro-6-vinyl-7-hydroxy-furo-(3,4-c)pyridin-derivater, fremgangsmaade til fremstilling af disse samt farmaceutisk praeparat indeholdende disse
DK164594C (da)	1992-12-07	1,4-dihydro-pyridin-3,5-yl-dicarboxylsyrederivater, farmaceutiske praeparater indeholdende disse derivater samt fremgangsmaade til fremstilling deraf
DK545684D0 (da)	1984-11-16	1,3-dihydro-6-methyl-furo-(3,4-c)-pyridin-derivater, fremgangsmaade til fremstilling af disse samt farmaceutisk praeparat indeholdende disse
DK408186D0 (da)	1986-08-27	Podophyllotoxin og derivater deraf, fremgangsmaader til deres fremstilling og anvendelse samt farmaceutiske praeparater indeholdende forbindelserne
DK538885D0 (da)	1985-11-21	Imidazolylalkylguanidinderivater, fremgangsmaade til fremstilling herafsamt laegemidler indeholdende disse forbindelser
NO790917L (no)	1979-09-21	N-oksacyklyl-alkyl-piperidin, fremgangsmaate til deres fremstilling, farmasoeytiske preparater inneholdende disse forbindelser, samt deres terapeutiske anvendelse
DK342187D0 (da)	1987-07-03	4-pyridin-derivater, fremgangsmaade til fremstilling af saadanne derivater samt farmaceutiske praeparater indeholdende disse
NO822062L (no)	1982-12-23	Substituerte imidazo(1,5-alfa)pyridiner, fremgangsmaate til deres fremstilling, farmasoeytiske preparater inneholdende disse forbindelser samt deres terapeutiske anvendelse
DK396385A (da)	1986-04-15	2,3-dihydro-lh-indenderivater, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende disse forbindelser
DK307085D0 (da)	1985-07-04	4-phenyl-2-trifluormethyl-1,3-dioxan-5-ylheptensyrederivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
DK159854C (da)	1991-05-13	N6-substituerede adenosinderivater, fremstilling af disse samt farmaceutiske praeparater indeholdende saadanne forbindelser
DK162984C (da)	1992-06-01	1-(2-ar-2-halogen-2-ethenyl)-1h-azoler, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende disse
DK87687D0 (da)	1987-02-20	1,6-naphthyridinderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende dem
DK191086D0 (da)	1986-04-24	Benzisoselenazolonylderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
DK617684D0 (da)	1984-12-20	1,3-dioxolanylderivater, fremgangsmaade til deres fremstilling, deres anvendelse og laegemidler indeholdende disse forbindelser
DK356985D0 (da)	1985-08-06	Imidazo(1,2-a)quinolinderivater samt fremgangsmaade til fremstilling afog laegemiddel indeholdende saadanne forbindelser
NO830966L (no)	1983-09-20	Sulfonylurinstoffer, fremgangsmaate til deres fremstilling, farmasoeytiske preparater paa basis av disse forbindelser, og deres anvendelse
DK93385A (da)	1985-09-02	3-amino-1-(4,5,6,7-tetrahydro-benzothiazolyl)-2-pyrazoliner, fremgangsmaade til fremstilling af disse forbindelser og farmaceutiske praeparater indeholdende disse forbindelser